Q2 FY2025 Earnings
Financial report interval: 2025.03.30 - 2025.06.30
Overview: ALTAMIRA THERAPEUTICS LTD(CYTOF) the EBIT is -1.314 M (+32.89%);the EPS is -0.153 (+85.47%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B32.89%
----
----
EPS
-0.15385.47%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf